Are COAG insiders buying or selling?

No COAG insiders reported open-market purchases or sales in the last 90 days.

When was the last COAG insider purchase?

No open-market insider purchase of Hemab Therapeutics Holdings, Inc. stock was reported in the last 90 days.

Where does COAG insider trading data come from?

Watch Insiders reads the SEC Form 4 filings that Hemab Therapeutics Holdings, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.

COAGSector not reported

Hemab Therapeutics Holdings, Inc. (COAG) Insider Trading

In the last 90 days, no Hemab Therapeutics Holdings, Inc. (COAG) insiders reported open-market purchases or sales on SEC Form 4.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers: 0
90-day purchase value: $0.00
Corporate buyers: 0
Latest transaction: Jun 16, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
Date	Insider name	Role	Type	Shares	Price	Total value
Jun 16, 2026	RA Capital Healthcare Fund LP	Corporate insider	Open Market Purchase	67,669	$24.97	$1,689,817
Jun 16, 2026	Ra Capital Management L.P.	10% Owner	Open Market Purchase	67,669	$24.97	$1,689,817
Jun 16, 2026	Peter Kolchinsky	Corporate insider	Open Market Purchase	67,669	$24.97	$1,689,817
Jun 16, 2026	Rajeev M. Shah	Corporate insider	Open Market Purchase	67,669	$24.97	$1,689,817
May 20, 2026	RA Capital Healthcare Fund LP	Corporate insider	Open Market Purchase	4,798	$24.96	$119,776
May 20, 2026	Ra Capital Management L.P.	10% Owner	Open Market Purchase	4,798	$24.96	$119,776
May 20, 2026	Peter Kolchinsky	Corporate insider	Open Market Purchase	4,798	$24.96	$119,776
May 20, 2026	Rajeev M. Shah	Corporate insider	Open Market Purchase	4,798	$24.96	$119,776
May 12, 2026	RA Capital Healthcare Fund LP	Corporate insider	Open Market Purchase	6,387	$24.90	$159,036
May 12, 2026	Ra Capital Management L.P.	10% Owner	Open Market Purchase	6,387	$24.90	$159,036
[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]
[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]	[🔒 Locked]

🔒 Create Free Insider Alerts — Join Watch Insiders

Common questions

COAG insider trading FAQ

Are COAG insiders buying or selling?: No COAG insiders reported open-market purchases or sales in the last 90 days.
When was the last COAG insider purchase?: No open-market insider purchase of Hemab Therapeutics Holdings, Inc. stock was reported in the last 90 days.
Where does COAG insider trading data come from?: Watch Insiders reads the SEC Form 4 filings that Hemab Therapeutics Holdings, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.